Search results
Found 7347 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
MLSTF Summer 2024 - Minutes
Minutes from MLSTF 2024 Panel meeting
Guidance For Applicants FA Alliance Catalyst
Guidance For Applicants